RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.35
−5.75%Oct 28, 2026, 20:12 UTC
Relay Therapeutics, Inc. said it will report its third-quarter 2026 financial results and corporate highlights after U.S. markets close on November 4, 2026.
Source:Aug 7, 2026, 00:12 UTC
Relay Therapeutics, Inc. reported a second-quarter loss of $0.41 per share, in line with the Zacks Consensus Estimate and unchanged from the year-ago quarter.
Source: